In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...
State support and the decisions taken by the government made it possible to correctly invest credit money so that the enterprise could operate and meet its obligations,” said Yuri Shuleiko.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results